Pharma Journalist - Page 857 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Amgen And UCB Provide Update On Regulatory Status Of EVENITY In The US

Valeant Agrees To Sell Obagi Medical Products Business

Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma

Roche’s OCREVUS approved for relapsing and primary progressive multiple sclerosis in Australia

Lilly Reaches Settlement Agreement in U.S. Cialis Patent Litigation

Biognosys raises new funds to bring Proteomics to life science research market

Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL

New improved BNF and BNFC app launched

FDA Grants Fast Track Designation to VT-1598 for Treatment of Valley Fever

ShangPharma Innovation and the University of California San Francisco Announce Strategic Research Collaboration